STOCK TITAN

[8-K] LIVEPERSON INC Reports Material Event

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

LivePerson, Inc. appointed Ryan L. Vardeman as a Class III director effective October 14, 2025, with a term expiring at the 2027 Annual Meeting of Stockholders. He was nominated pursuant to the previously announced Exchange Agreement with certain former holders of the Company’s 0% Senior Convertible Notes due 2026, following the Company’s standard governance processes.

The Company disclosed under Item 404(a) that Palogic Value Fund, LP—affiliated with Mr. Vardeman—participated as a Noteholder in the exchange and received approximately $1.3 million in cash, approximately $3.3 million principal amount of Second Lien Senior Subordinated Secured Notes due 2029, 1,592,984 shares (or 106,198 post‑reverse‑split) of common stock, and 762 shares of Series B Fixed Rate Convertible Perpetual Preferred Stock. Mr. Vardeman will receive standard director compensation and an initial equity grant under the Amended and Restated 2019 Stock Incentive Plan. A press release announcing the appointment is furnished as Exhibit 99.1.

LivePerson, Inc. ha nominato Ryan L. Vardeman come consigliere di Classe III con effetto dal 14 ottobre 2025, con mandato che scadrà alla Riunione Annuale degli Azionisti del 2027. È stato nominato ai sensi dell'accordo di scambio precedentemente annunciato con alcuni ex titolari delle Note Convertibili Senior 0% in scadenza nel 2026, secondo i normali processi di governance della Società.

La Società ha comunicato ai sensi della voce 404(a) che Palogic Value Fund, LP – affiliato al Sig. Vardeman – ha partecipato come ottenitore di Note nello scambio e ha ricevuto circa 1,3 milioni di dollari in contanti, circa 3,3 milioni di dollari in valore principale di Note Senior Subordinated Securitized Note Seconda Ipoteca scadenza 2029, 1.592.984 azioni (ovvero 106.198 dopo lo split inverso) di azioni ordinarie, e 762 azioni di Series B Fixed Rate Convertible Perpetual Preferred Stock. Il Sig. Vardeman percepirà la normale compensazione da direttore e una concessione iniziale di capitale ai sensi del piano di stock incentive Amendato e Restato 2019. Un comunicato stampa che annuncia la nomina è fornito come Exhibit 99.1.

LivePerson, Inc. designó a Ryan L. Vardeman como director de Clase III con efecto a partir del 14 de octubre de 2025, con un mandato que vencerá en la Junta Anual de Accionistas de 2027. Fue nominado conforme al Acuerdo de Intercambio previamente anunciado con ciertos ex tenedores de las Notas Convertibles Senior 0% con vencimiento en 2026, siguiendo los procesos de gobernanza habituales de la Compañía.

La Compañía informó según el Item 404(a) que Palogic Value Fund, LP, afiliado al Sr. Vardeman, participó como tenedor de notas en el intercambio y recibió aproximadamente 1,3 millones de dólares en efectivo, aproximadamente 3,3 millones de dólares en importe principal de Notas Senior Subordinadas con Garantía de Segunda Prueba de Deuda vencimiento 2029, 1.592.984 acciones (o 106.198 tras el split inverso) de acciones ordinarias, y 762 acciones de Series B Fixed Rate Convertible Perpetual Preferred Stock. El Sr. Vardeman recibirá la compensación normal de director y una asignación inicial de capital bajo el Amended and Restated 2019 Stock Incentive Plan. Un comunicado de prensa anunciando la designación se proporciona como el Exhibit 99.1.

LivePerson, Inc.가 2025년 10월 14일부로 Class III 이사진으로 Ryan L. Vardeman을 임명했으며, 임기는 2027년 주주총회에서 만료됩니다. 이사는 회사의 일반적인 거버넌스 절차에 따라 2026년 만기 0% 고정금리 선순위 전환사채를 보유한 특정 전 주주들과의 교환 계약에 따라 지명되었습니다.

회사는 Item 404(a) 아래 Palogic Value Fund, LP가 Vardeman 씨와 연계된 채권자 노트홀더로서 교환에 참여했고 현금 약 130만 달러, 2029년 만기인 제2선위선순위 담보채권 약 330만 달러의 명목가액, 보통주 1,592,984주(역분할 후 106,198주), 그리고 Series B 고정금리 전환형 영구우선주 762주를 수령했다고 공시했습니다. Vardeman 씨는 이사 보상과 2019년 수정 및 재정의 주식 인센티브 계획에 따른 초기 주식 보상을 받게 됩니다. 지명을 발표하는 보도자료가 Exhibit 99.1로 제공됩니다.

LivePerson, Inc. a nommé Ryan L. Vardeman en tant que administrateur de classe III avec effet à compter du 14 octobre 2025, pour un mandat expirant lors de l’Assemblée générale annuelle des actionnaires de 2027. Il a été nommé conformément à l’accord d’échange annoncé précédemment avec certains anciens détenteurs des Notes Convertibles Seniors 0% d’échéance en 2026, conformément aux processus de gouvernance habituels de la Société.

La Société a divulgué en vertu de l’article 404(a) que Palogic Value Fund, LP – affilié à M. Vardeman – a participé en tant que détenteur de notes dans l’échange et a reçu environ 1,3 million de dollars en espèces, environ 3,3 millions de dollars en montant principal de Notes Senior Subordonnés Garanties de Secondier rang, échéant en 2029, 1 592 984 actions (ou 106 198 après la scission inverse) d’actions ordinaires, et 762 actions de Series B Fixed Rate Convertible Perpetual Preferred Stock. M. Vardeman recevra la compensation standard des administrateurs et une attribution initiale d’actions au titre du Amended and Restated 2019 Stock Incentive Plan. Un communiqué de presse annonçant la nomination est fourni comme Exhibit 99.1.

LivePerson, Inc. hat Ryan L. Vardeman zum Class-III-Direktor mit Wirkung vom 14. Oktober 2025 ernannt, mit einer Amtszeit, die auf der Jahreshauptversammlung der Aktionäre 2027 endet. Er wurde gemäß der zuvor angekündigten Austauschvereinbarung mit bestimmten ehemaligen Inhabern der 0% Senior Convertible Notes fällig 2026 nominiert, gemäß den üblichen Governance-Prozessen des Unternehmens.

Unter Item 404(a) gab das Unternehmen bekannt, dass Palogic Value Fund, LP – mit Herrn Vardeman verbunden – als Noteholder am Austausch teilnahm und ca. 1,3 Mio. USD in bar, ca. 3,3 Mio. USD Hauptsumme der Second Lien Senior Subordinated Secured Notes fällig 2029, 1.592.984 Aktien (bzw. 106.198 nach dem Reverse-Split) Stammaktien und 762 Aktien der Series B Fixed Rate Convertible Perpetual Preferred Stock erhielt. Herr Vardeman wird die übliche Direktorengebühr sowie eine anfängliche Aktienzuteilung gemäß dem Amended and Restated 2019 Stock Incentive Plan erhalten. Eine Pressemitteilung zur Ernennung ist als Exhibit 99.1 beigefügt.

LivePerson, Inc. عيّنت Ryan L. Vardeman كمدير من الصف الثالث اعتباراً من 14 أكتوبر 2025، لمدة تنتهي عند اجتماع المساهمين السنوي 2027. تم ترشيحه وفقاً لاتفاقية التبادل المعلنة سابقاً مع بعض حملة Notes Senior Convertible من فئة 0% التي تستحق في 2026، وفقاً لعمليات الحوكمة القياسية للشركة.

كشفت الشركة بموجب البند 404(a) أن Palogic Value Fund, LP – المرتبط بالسيد فارديمان – شارك كـ Noteholder في التبادل وتلقى نحو 1.3 مليون دولار نقداً، نحو 3.3 مليون دولار كالمبلغ الأساسي لـ Second Lien Senior Subordinated Secured Notes المستحقة 2029، و1,592,984 سهماً (أو 106,198 بعد التقسيم العكسي) من الأسهم العادية، و762 سهماً من Series B Fixed Rate Convertible Perpetual Preferred Stock. سيحصل السيد فارديمان على تعويض المدير العادي وإعانة أسهم ابتدائية بموجب خطة الحوافز الأسهم المعدلة والمراجعة 2019. يُقدَّم بيان صحفي يعلن التعيين ك Exhibit 99.1.

LivePerson, Inc. 已任命 Ryan L. Vardeman 为 Class III 董事,自 2025 年 10 月 14 日起生效,任期至 2027 年股东年会结束。他根据事先宣布的与若干前所有者的 0% 优先可转债(到期日为 2026)之交易协议被提名,遵循公司的一般治理流程。

公司在 Item 404(a 下披露,与 Vardeman 先生有关联的 Palogic Value Fund, LP 作为 Noteholder 参与了交易,并收到约 130 万美元现金、约 330 万美元的次级留置担保票据(Second Lien Senior Subordinated Secured Notes,期限至 2029)的本金额、1,592,984 股(逆转分割后为 106,198 股)普通股,以及 762 股 Series B Fixed Rate Convertible Perpetual Preferred Stock。Vardeman 先生将获得董事的标准报酬,以及根据修订并重新表述的 2019 年股票激励计划的初始股权授权。宣布任命的新闻稿作为 Exhibit 99.1 提供。

Positive
  • None.
Negative
  • None.

Insights

Director added via prior exchange agreement; related-party terms disclosed.

LivePerson added Ryan L. Vardeman to its board as a Class III director on October 14, 2025, with the nomination tied to an Exchange Agreement involving former holders of 0% Senior Convertible Notes due 2026. The filing also notes standard director pay and an initial equity grant under the 2019 plan.

Item 404(a) details that Palogic Value Fund, LP, affiliated with Mr. Vardeman, participated in the exchange and received $1.3 million in cash, $3.3 million principal of Second Lien Senior Subordinated Secured Notes due 2029, 1,592,984 shares (or 106,198 post‑reverse‑split) of common stock, and 762 shares of Series B Fixed Rate Convertible Perpetual Preferred Stock. This is standard related‑party transparency.

Committee assignments will be disclosed later. Actual governance impact depends on future board roles and decisions; the event itself is administrative and does not change financial outlook.

LivePerson, Inc. ha nominato Ryan L. Vardeman come consigliere di Classe III con effetto dal 14 ottobre 2025, con mandato che scadrà alla Riunione Annuale degli Azionisti del 2027. È stato nominato ai sensi dell'accordo di scambio precedentemente annunciato con alcuni ex titolari delle Note Convertibili Senior 0% in scadenza nel 2026, secondo i normali processi di governance della Società.

La Società ha comunicato ai sensi della voce 404(a) che Palogic Value Fund, LP – affiliato al Sig. Vardeman – ha partecipato come ottenitore di Note nello scambio e ha ricevuto circa 1,3 milioni di dollari in contanti, circa 3,3 milioni di dollari in valore principale di Note Senior Subordinated Securitized Note Seconda Ipoteca scadenza 2029, 1.592.984 azioni (ovvero 106.198 dopo lo split inverso) di azioni ordinarie, e 762 azioni di Series B Fixed Rate Convertible Perpetual Preferred Stock. Il Sig. Vardeman percepirà la normale compensazione da direttore e una concessione iniziale di capitale ai sensi del piano di stock incentive Amendato e Restato 2019. Un comunicato stampa che annuncia la nomina è fornito come Exhibit 99.1.

LivePerson, Inc. designó a Ryan L. Vardeman como director de Clase III con efecto a partir del 14 de octubre de 2025, con un mandato que vencerá en la Junta Anual de Accionistas de 2027. Fue nominado conforme al Acuerdo de Intercambio previamente anunciado con ciertos ex tenedores de las Notas Convertibles Senior 0% con vencimiento en 2026, siguiendo los procesos de gobernanza habituales de la Compañía.

La Compañía informó según el Item 404(a) que Palogic Value Fund, LP, afiliado al Sr. Vardeman, participó como tenedor de notas en el intercambio y recibió aproximadamente 1,3 millones de dólares en efectivo, aproximadamente 3,3 millones de dólares en importe principal de Notas Senior Subordinadas con Garantía de Segunda Prueba de Deuda vencimiento 2029, 1.592.984 acciones (o 106.198 tras el split inverso) de acciones ordinarias, y 762 acciones de Series B Fixed Rate Convertible Perpetual Preferred Stock. El Sr. Vardeman recibirá la compensación normal de director y una asignación inicial de capital bajo el Amended and Restated 2019 Stock Incentive Plan. Un comunicado de prensa anunciando la designación se proporciona como el Exhibit 99.1.

LivePerson, Inc.가 2025년 10월 14일부로 Class III 이사진으로 Ryan L. Vardeman을 임명했으며, 임기는 2027년 주주총회에서 만료됩니다. 이사는 회사의 일반적인 거버넌스 절차에 따라 2026년 만기 0% 고정금리 선순위 전환사채를 보유한 특정 전 주주들과의 교환 계약에 따라 지명되었습니다.

회사는 Item 404(a) 아래 Palogic Value Fund, LP가 Vardeman 씨와 연계된 채권자 노트홀더로서 교환에 참여했고 현금 약 130만 달러, 2029년 만기인 제2선위선순위 담보채권 약 330만 달러의 명목가액, 보통주 1,592,984주(역분할 후 106,198주), 그리고 Series B 고정금리 전환형 영구우선주 762주를 수령했다고 공시했습니다. Vardeman 씨는 이사 보상과 2019년 수정 및 재정의 주식 인센티브 계획에 따른 초기 주식 보상을 받게 됩니다. 지명을 발표하는 보도자료가 Exhibit 99.1로 제공됩니다.

LivePerson, Inc. a nommé Ryan L. Vardeman en tant que administrateur de classe III avec effet à compter du 14 octobre 2025, pour un mandat expirant lors de l’Assemblée générale annuelle des actionnaires de 2027. Il a été nommé conformément à l’accord d’échange annoncé précédemment avec certains anciens détenteurs des Notes Convertibles Seniors 0% d’échéance en 2026, conformément aux processus de gouvernance habituels de la Société.

La Société a divulgué en vertu de l’article 404(a) que Palogic Value Fund, LP – affilié à M. Vardeman – a participé en tant que détenteur de notes dans l’échange et a reçu environ 1,3 million de dollars en espèces, environ 3,3 millions de dollars en montant principal de Notes Senior Subordonnés Garanties de Secondier rang, échéant en 2029, 1 592 984 actions (ou 106 198 après la scission inverse) d’actions ordinaires, et 762 actions de Series B Fixed Rate Convertible Perpetual Preferred Stock. M. Vardeman recevra la compensation standard des administrateurs et une attribution initiale d’actions au titre du Amended and Restated 2019 Stock Incentive Plan. Un communiqué de presse annonçant la nomination est fourni comme Exhibit 99.1.

LivePerson, Inc. hat Ryan L. Vardeman zum Class-III-Direktor mit Wirkung vom 14. Oktober 2025 ernannt, mit einer Amtszeit, die auf der Jahreshauptversammlung der Aktionäre 2027 endet. Er wurde gemäß der zuvor angekündigten Austauschvereinbarung mit bestimmten ehemaligen Inhabern der 0% Senior Convertible Notes fällig 2026 nominiert, gemäß den üblichen Governance-Prozessen des Unternehmens.

Unter Item 404(a) gab das Unternehmen bekannt, dass Palogic Value Fund, LP – mit Herrn Vardeman verbunden – als Noteholder am Austausch teilnahm und ca. 1,3 Mio. USD in bar, ca. 3,3 Mio. USD Hauptsumme der Second Lien Senior Subordinated Secured Notes fällig 2029, 1.592.984 Aktien (bzw. 106.198 nach dem Reverse-Split) Stammaktien und 762 Aktien der Series B Fixed Rate Convertible Perpetual Preferred Stock erhielt. Herr Vardeman wird die übliche Direktorengebühr sowie eine anfängliche Aktienzuteilung gemäß dem Amended and Restated 2019 Stock Incentive Plan erhalten. Eine Pressemitteilung zur Ernennung ist als Exhibit 99.1 beigefügt.

0001102993false00011029932025-10-142025-10-140001102993us-gaap:CommonStockMember2025-10-142025-10-140001102993us-gaap:RightsMember2025-10-142025-10-14

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549 
_____________________

FORM 8-K
____________________
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
  Date of Report (Date of earliest event reported): October 14, 2025

LivePerson, Inc.
(Exact Name of Registrant as Specified in its Charter)

Delaware
001-41926
13-3861628
(State or other jurisdiction
of incorporation)
(Commission File Number)(I.R.S. Employer
Identification No.)

530 7th Ave, Floor M1
New York, New York 10018
(Address of principal executive offices, with zip code)

(212) 609-4200
Registrants telephone number, including area code

N/A
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, par value $0.001 per shareLPSNThe Nasdaq Stock Market LLC
Rights to Purchase Series A Junior Participating Preferred StockNoneThe Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 




Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On October 14, 2025, the Board of Directors (the “Board”) of LivePerson, Inc. (the “Company”) appointed Ryan L. Vardeman as a Class III director of the Board, with a term expiring as of the Company’s 2027 Annual Meeting of Stockholders. Mr. Vardeman was nominated pursuant to the terms of the previously announced Exchange Agreement, dated August 11, 2025 (the “Exchange Agreement”), by and among the Company and certain former holders (each, a “Noteholder”, and collectively, the “Noteholders”) of the Company’s 0% Senior Convertible Notes due 2026 (the “2026 Notes”), together with thorough review pursuant to the Company’s standard nominating and corporate governance processes. Any committee appointments for Mr. Vardeman will be subsequently disclosed.

Mr. Vardeman serves as a principal of Palogic Value Management, L.P., a Dallas, Texas based investment management company co-founded by Mr. Vardeman in January 2007. Mr. Vardeman has extensive corporate strategy, operating, financial and investment experience including capital structure analysis, with a focus on small-cap equities, and investing in a broad range of industries with an emphasis on technology and software companies. Mr. Vardeman previously served on the board of directors of BSQUARE Corporation from 2018 to 2023 (including serving as the Chairman of the board of directors, Chairman of the Compensation Committee, and a member of the Governance and Nominating Committee), and INTEVAC, Inc. from November 2024 to March 2025. Mr. Vardeman holds a B.S. in Electrical Engineering and Computer Science from Texas Tech University and an M.B.A. from the Owen Graduate School of Management at Vanderbilt University.

Mr. Vardeman will receive standard annual director fees and benefits, as well as an initial grant of equity under the Company’s Amended and Restated 2019 Stock Incentive Plan.

The Company intends to enter into its form of director and executive officer indemnification agreement with Mr. Vardeman, a copy of which has been filed as Exhibit 10.6 to the Company’s Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission on March 13, 2012.

Item 404(a) disclosure

Palogic Value Fund, LP, the general partner of which is Palogic Value Management LP, participated as a Noteholder in the transactions contemplated by the Exchange Agreement, and received as consideration for the exchange of its 2026 Notes (i) approximately $1.3 million in cash, (ii) approximately $3.3 million principal amount of the Company’s Second Lien Senior Subordinated Secured Notes due 2029, (iii) 1,592,984 shares (or 106,198 shares on a post-reverse-split basis) of the Company’s common stock, par value $0.001 per share, and (iv) 762 shares of the Company’s Series B Fixed Rate Convertible Perpetual Preferred Stock.


Item 8.01 Other Events.

On October 20, 2025, the Company issued a press release announcing the appointment of Mr. Vardeman. A copy of this press release is attached as Exhibit 99.1 to this current report on Form 8-K and incorporated herein by reference.


Item 9.01. Financial Statements and Exhibits.

(d) Exhibits. The following documents are included as exhibits to this report:

Exhibit No.Description
99.1
Press Release issued by the Company on October 20, 2025.
104.1Cover Page Interactive Data File (embedded within the Inline XBRL document).









SIGNATURE


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date:    October 20, 2025                
LIVEPERSON, INC.
(Registrant)

By:    /s/ MONICA L. GREENBERG    
Monica L. Greenberg
Executive Vice President, Policy and General Counsel


FAQ

Who did LivePerson (LPSN) appoint to its board and when?

LivePerson appointed Ryan L. Vardeman as a Class III director effective October 14, 2025.

What is the term of Ryan Vardeman’s directorship at LPSN?

His term expires at LivePerson’s 2027 Annual Meeting of Stockholders.

Why was Ryan Vardeman nominated to the LivePerson board?

He was nominated under the Exchange Agreement with former holders of the Company’s 0% Senior Convertible Notes due 2026, alongside standard governance review.

What related-party exchange consideration did Palogic Value Fund receive?

Approximately $1.3 million cash; $3.3 million principal of Second Lien Senior Subordinated Secured Notes due 2029; 1,592,984 common shares (or 106,198 post‑reverse‑split); and 762 Series B preferred shares.

What compensation will Ryan Vardeman receive from LivePerson?

He will receive standard annual director fees and an initial equity grant under the Amended and Restated 2019 Stock Incentive Plan.

Did LivePerson provide a press release about the appointment?

Yes. A press release dated October 20, 2025 is furnished as Exhibit 99.1.
Liveperson Inc

NASDAQ:LPSN

LPSN Rankings

LPSN Latest News

LPSN Latest SEC Filings

LPSN Stock Data

63.65M
8.81M
4.12%
23.27%
8.22%
Software - Application
Services-prepackaged Software
Link
United States
NEW YORK